Related Experiment Video
Updated: Sep 7, 2025

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
A mouse model for Li-Fraumeni-Like Syndrome with cardiac angiosarcomas associated to POT1 mutations
Paula Martínez1, Raúl Sánchez-Vázquez1, Iole Ferrara-Romeo1
1Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain.
Abstract:
The shelterin protein POT1 has been found mutated in many different familial and sporadic cancers, however, no mouse models to understand the pathobiology of these mutations have been developed so far. To address the molecular mechanisms underlying the tumorigenic effects of POT1 mutant proteins in humans, we have generated a mouse model for the human POT1R117C mutation found in Li-Fraumeni-Like families with cases of cardiac angiosarcoma by introducing this mutation in the Pot1a endogenous locus, knock-in for Pot1aR117C. We find here that both mouse embryonic fibroblasts (MEFs) and tissues from Pot1a+/ki mice show longer telomeres than wild-type controls. Longer telomeres in Pot1a+/ki MEFs are dependent on telomerase activity as they are not found in double mutant Pot1a+/ki Tert-/- telomerase-deficient MEFs. By using complementation assays we further show that POT1a pR117C exerts dominant-negative effects at telomeres. As in human Li-Fraumeni patients, heterozygous Pot1a+/ki mice spontaneously develop a high incidence of angiosarcomas, including cardiac angiosarcomas, and this is associated to the presence of abnormally long telomeres in endothelial cells as well as in the tumors. The Pot1a+/R117C mouse model constitutes a useful tool to understand human cancers initiated by POT1 mutations.
Insights
A new mouse model carrying a POT1 mutation (POT1R117C) develops angiosarcomas, mirroring human cancers. This model reveals POT1 mutations cause longer telomeres and dominant-negative effects, aiding cancer research.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Mutations in the shelterin protein POT1 are implicated in various cancers.
- Existing research lacks suitable animal models to study POT1-related tumorigenesis.
Purpose of the Study:
- To generate and characterize a mouse model for the human POT1R117C mutation.
- To investigate the molecular mechanisms of POT1 mutant proteins in cancer development.
Main Methods:
- Generated a knock-in mouse model (Pot1a+/ki) for the human POT1R117C mutation.
- Analyzed telomere length in mouse embryonic fibroblasts (MEFs) and tissues.
- Utilized complementation assays to assess POT1a pR117C effects.
- Examined tumor incidence and telomere length in tumor cells.
Main Results:
- Pot1a+/ki mice and MEFs exhibit significantly longer telomeres compared to wild-type.
- Longer telomeres in MEFs are telomerase-dependent.
- POT1a pR117C demonstrates dominant-negative effects at telomeres.
- Pot1a+/ki mice develop a high incidence of angiosarcomas, including cardiac angiosarcomas, with abnormally long telomeres.
Conclusions:
- The Pot1a+/R117C mouse model accurately recapitulates human POT1-mutated cancers.
- This model provides a valuable tool for studying the pathobiology of POT1-driven human cancers.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024